APO 131 (Carbidopa and Levodopa Extended Release 25 mg / 100 mg)

Pill with imprint APO 131 is Red, Round and has been identified as Carbidopa and Levodopa Extended Release 25 mg / 100 mg. It is supplied by Apotex Corp..

Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 131

Carbidopa and Levodopa Extended Release

Imprint:

APO 131

Strength:

25 mg / 100 mg

Color:

Red

Size:

8.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Apotex Corp.

National Drug Code (NDC):

60505-0131

Inactive Ingredients:

• hypromelloses
• magnesium stearate
• ferric oxide red

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer